- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04499417
Psychological and Physical Effects of an 8-Week Electromyostimulation-Workout
Psychological and Physical Effects of an 8-Week Electromyostimulation-Whole-Body-Workout
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Antonia Bendau, M.Sc.Psych.
- Phone Number: +4930450517274
- Email: antonia.bendau@charite.de
Study Contact Backup
- Name: Andreas Ströhle, Prof.Dr.
- Phone Number: +4930450517217
- Email: andreas.stroehle@charite.de
Study Locations
-
-
-
Berlin, Germany, 10117
- Recruiting
- Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
-
Contact:
- Email: ems@charite.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subject familiarized with experimental procedure and had given written informed consent
- Able to understand German
- Reachability of participant for the eight training sessions
Exclusion Criteria:
- Contraindications for physical exercise or EMS-use
- Current EMS-use or intense regular exercise (> 60 min / week)
- Pregnancy
- Current presence of any mental disease
- Acute suicidality
- Substance dependencies with actual consumption (except nicotine)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental-Condition
8 weeks x weekly 20 minutes whole-body-workouts with simultaneous muscle stimulation (EMS). Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout the muscles are simultaneously stimulated by those external electrodes with medium level (5) of stimulation intensity. |
Electromyostimulation - intensity 5 (muscle stimulation)
Other Names:
|
Sham Comparator: Sham-Condition
8 weeks x weekly 20 minutes whole-body-workouts without simultaneous muscle stimulation (EMS). Participants carry out easy whole-body-exercises while wearing a EMS-vest-belt-system with interwoven electrodes. During the workout the muscles are not actually stimulated by EMS. |
Electromyostimulation - intensity 0 (no muscle stimulation)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acute change of subjective well-being.
Time Frame: From directly before each of the eight training sessions do directly after each of the sessions (EMS-Training/Sham) during the 8 weeks of training.
|
• Subjective well-being is measured using a visual analogue scale (0-100%, higher value = better outcome).
|
From directly before each of the eight training sessions do directly after each of the sessions (EMS-Training/Sham) during the 8 weeks of training.
|
Acute change of subjective relaxation.
Time Frame: From directly before each of the eight training sessions do directly after each of the sessions (EMS-Training/Sham) during the 8 weeks of training.
|
• Subjective relaxation is measured using a visual analogue scale (0-100%, higher value = better outcome).
|
From directly before each of the eight training sessions do directly after each of the sessions (EMS-Training/Sham) during the 8 weeks of training.
|
Change of acute symptoms of anxiety and depression.
Time Frame: From directly before each of the eight training sessions do directly after each of the sessions (EMS-Training/Sham) during the 8 weeks of training.
|
• The State-Scale of the State-Trait-Anxiety-Depression-Inventar (STADI-State; Renner, Hock, Bergner-Köther & Laux, 2018) is used to assess acute symptoms of depression and anxiety.
The raw score ranges from 10 to 40, higher values indicate a worse outcome.
|
From directly before each of the eight training sessions do directly after each of the sessions (EMS-Training/Sham) during the 8 weeks of training.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mid-/longterm changes in depressive symptoms.
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• Patient Health Questionnaire (PHQ-9; Kroenke & Spitzer, 2002).
Sum scores ranging from 0 to 27, higher values indicate a worse outcome.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Mid-/longterm changes in anxiety symptoms.
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• Generalized Anxiety Disorder Scale (GAD-7; Spitzer, Kroenke, Williams & Löwe, 2006).
Sum scores ranging from 0 to 21, higher values indicate a worse outcome.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Mid-/longterm changes in affect-related psychological variables.
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• The Trait-Scale of the State-Trait-Anxiety-Depression-Inventar (STADI-Trait; Renner, Hock, Bergner-Köther & Laux, 2018) is used to assess symptoms of depression and anxiety.
The raw score ranges from 10 to 40, higher values indicate a worse outcome.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Mid-/longterm changes in positive and negative affect.
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• Positive and Negative Affect Schedule (PANAS; Watson, Clark & Tellegen, 1988).
Positive subscale: Scores ranging from 10 to 50, higher scores represent a better outcome.
Negative subscale: Scores ranging from 10 to 50, higher scores represent a worse outcome.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Change in general self-efficacy
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• General self-efficacy is measured using the General-Self-Efficacy Scale (GSE) by Jerusalem & Schwarzer (1981).
The GSE has 10 likert scaled items with values ranging from 1 to 4, higher scores mean a better outcome.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Change in attitudes regarding physical activity (intentions for physical activity, self-efficacy regarding physical activity)
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• Intention (4 items) and self-efficacy (2 items) are measured using six likert scaled items by Petzold et al. (2017).
Values ranging from 1 to 4, higher scores mean a better outcome.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Change in physical parameters: heart rate variability.
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• Heart rate variability is measured with a polar chest strap during 5 minutes of relaxation.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Change in physical parameters: hand force.
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• Hand force is measured with a hand-dynamometer left and right hand.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Change in physical parameters: leg strength.
Time Frame: Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
• Leg strength is assessed using the 30-second chair-stand-test.
|
Baseline (before any training) + Intermediate (4 weeks) + Post (8 weeks) + Follow-Up (12 weeks).
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Andreas Ströhle, Prof.Dr., Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
- Principal Investigator: Antonia Bendau, M.Sc.Psych., Charité-Universitätsmedizin Berlin - Department of Psychiatry and Psychotherapy
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EA4/058/19 (longterm trial)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Hasselt UniversityRecruitingHealthy | Healthy AgingBelgium
-
Galera Therapeutics, Inc.Syneos HealthCompleted
-
Galera Therapeutics, Inc.Syneos HealthCompletedHealthy | Healthy VolunteersAustralia
-
University of PennsylvaniaActive, not recruitingHealthy | Healthy AgingUnited States
-
Chalmers University of TechnologyGöteborg UniversityCompletedHealthy | Nutrition, HealthySweden
-
University of ManitobaNot yet recruitingHealthy | Healthy Diet
Clinical Trials on Electromyostimulation Whole-Body-Workout
-
Federal University of Health Science of Porto AlegreLeonhardt Ventures LLCNot yet recruiting
-
University of Erlangen-Nürnberg Medical SchoolParacelsus Medical UniversityCompleted
-
Federal University of Health Science of Porto AlegreCompletedChronic Obstructive Pulmonary DiseaseBrazil
-
Federal University of Health Science of Porto AlegreNot yet recruiting
-
University of Erlangen-Nürnberg Medical SchoolUnknownLymphoma | Hematologic Diseases | Leukemia | Cancer | Myeloma | Cachexia; CancerGermany
-
University of Erlangen-Nürnberg Medical SchoolActive, not recruiting
-
University of Erlangen-Nürnberg Medical SchoolCompletedCancer | Muscle Weakness | Weight Loss | Cancer Cachexia | Muscle LossGermany
-
University of Erlangen-Nürnberg Medical SchoolUnknownGynecologic Cancer | CachexiaGermany
-
University of Erlangen-Nürnberg Medical SchoolCompletedMuscle Strength | Trunk Stability | Golf Specific PerformanceGermany
-
Federal University of Health Science of Porto AlegreIrmandade Santa Casa de Misericórdia de Porto AlegreNot yet recruitingLung Transplantation | Electric StimulationBrazil